p62 upregulation is observed in most human CLDs that predispose to HCC progression [68], but whether there is a certain threshold or additional molecular requirements for p62 to elicit strong NRF2 activation is unclear. This evidence concerns the gene SQSTM1 and hepatocellular carcinoma.